IUHSA
AXDX

Itau Unibanco Holding S.A.’s Accelerate Diagnostics AXDX Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-590
Closed -$8K – 479
2022
Q1 		$8K Hold
590
– – ﹤0.01% 435
2021
Q4 		$30K Buy
590
+274
+87% +$15.3K ﹤0.01% 343
2021
Q3 		$18K Buy
316
+108
+52% +$7.04K ﹤0.01% 342
2021
Q2 		$17K Buy
+208
New +$16.5K ﹤0.01% 312

Other funds holding AXDX

GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

Itau Unibanco Holding S.A.'s AXDX Position: Q2 2022 in Review

Itau Unibanco Holding S.A. sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 590 shares — an estimated $8K sold.

Itau Unibanco Holding S.A. first reported a position in AXDX in Q2 2021 and held it in 4 quarters. The position peaked at $30K in Q4 2021. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • Itau Unibanco Holding S.A. reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 590 Accelerate Diagnostics shares in Q2 2022, an estimated $8K.
  • Itau Unibanco Holding S.A. first reported a position in Accelerate Diagnostics in Q2 2021 and held it in 4 quarters.
  • Itau Unibanco Holding S.A.'s Accelerate Diagnostics position peaked at $30K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2022, filed 15 Aug 2022.